You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
|
|---|---|
| Published in |
Cardiovascular Diabetology, June 2018
|
| DOI | 10.1186/s12933-018-0738-4 |
| Pubmed ID | |
| Authors |
Mariël F. van Stee, Albert A. de Graaf, Albert K. Groen |
| Abstract |
Patients with diabetes type 2 have an increased risk for cardiovascular disease and commonly use combination therapy consisting of the anti-diabetic drug metformin and a cholesterol-lowering statin. However, both drugs act on glucose and lipid metabolism which could lead to adverse effects when used in combination as compared to monotherapy. In this review, the proposed molecular mechanisms of action of statin and metformin therapy in patients with diabetes and dyslipidemia are critically assessed, and a hypothesis for mechanisms underlying interactions between these drugs in combination therapy is developed. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 50% |
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 198 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 198 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 24 | 12% |
| Student > Master | 21 | 11% |
| Student > Bachelor | 21 | 11% |
| Researcher | 14 | 7% |
| Other | 13 | 7% |
| Other | 23 | 12% |
| Unknown | 82 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 31 | 16% |
| Biochemistry, Genetics and Molecular Biology | 25 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 20 | 10% |
| Agricultural and Biological Sciences | 12 | 6% |
| Chemistry | 4 | 2% |
| Other | 17 | 9% |
| Unknown | 89 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2023.
All research outputs
#2,859,855
of 23,802,430 outputs
Outputs from Cardiovascular Diabetology
#193
of 1,450 outputs
Outputs of similar age
#58,336
of 329,864 outputs
Outputs of similar age from Cardiovascular Diabetology
#6
of 21 outputs
Altmetric has tracked 23,802,430 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,450 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 329,864 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.